About thirty years ago, generic (unbranded) drugs were first approved by the Federal Drug Administration (FDA) for use by patients. These drugs provided competitive alternatives to more expensive name branded pharmaceuticals, and this competition saved consumers $1.68 trillion (not billion) over the last decade, according to the FDA’s Deputy Commissioner. Lower prices from these alternatives made treatment more affordable, which opened up access to millions of patients. It indisputably saved lives and money.
While it may seem hard to image any group wanting to impede the introduction of lifesaving drugs into the market, there are some…
To continue reading, visit The Hill’s Congress Blog.